Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 1
2008 1
2009 1
2010 6
2011 4
2012 2
2013 5
2014 8
2015 21
2016 14
2017 17
2018 10
2019 6
2020 8
2021 5
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 25368012

97 results

Results by year

Filters applied: . Clear all
Page 1
PARP inhibitors for chemoprevention--reply.
To C, Sporn MB, Liby KT. To C, et al. Cancer Prev Res (Phila). 2014 Nov;7(11):1172. doi: 10.1158/1940-6207.CAPR-14-0264. Cancer Prev Res (Phila). 2014. PMID: 25368012 No abstract available.
PARP inhibitors for chemoprevention--letter.
Chand SN, Blanco FF, Jimbo M, Tsangaris TN, Cristofanilli M, Yeo CJ, Winter JM, Pishvaian MJ, Brody JR. Chand SN, et al. Cancer Prev Res (Phila). 2014 Nov;7(11):1170-1. doi: 10.1158/1940-6207.CAPR-14-0220. Cancer Prev Res (Phila). 2014. PMID: 25368011 No abstract available.
[Cancer therapy by PARP inhibitors].
Seimiya H. Seimiya H. Nihon Rinsho. 2015 Aug;73(8):1330-5. Nihon Rinsho. 2015. PMID: 26281686 Review. Japanese.
Loss of 53BP1 causes PARP inhibitor resistance in Brca1-mutated mouse mammary tumors.
Jaspers JE, Kersbergen A, Boon U, Sol W, van Deemter L, Zander SA, Drost R, Wientjens E, Ji J, Aly A, Doroshow JH, Cranston A, Martin NM, Lau A, O'Connor MJ, Ganesan S, Borst P, Jonkers J, Rottenberg S. Jaspers JE, et al. Cancer Discov. 2013 Jan;3(1):68-81. doi: 10.1158/2159-8290.CD-12-0049. Epub 2012 Oct 25. Cancer Discov. 2013. PMID: 23103855 Free PMC article.
Olaparib (Lynparza) for advanced ovarian cancer.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2016 Feb 29;58(1489):e32-3. Med Lett Drugs Ther. 2016. PMID: 26938702 Review. No abstract available.
PARP inhibitors in cancer: moving beyond BRCA.
Telli ML. Telli ML. Lancet Oncol. 2011 Sep;12(9):827-8. doi: 10.1016/S1470-2045(11)70236-4. Epub 2011 Aug 19. Lancet Oncol. 2011. PMID: 21862406 No abstract available.
High sensitivity of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugs.
Rottenberg S, Jaspers JE, Kersbergen A, van der Burg E, Nygren AO, Zander SA, Derksen PW, de Bruin M, Zevenhoven J, Lau A, Boulter R, Cranston A, O'Connor MJ, Martin NM, Borst P, Jonkers J. Rottenberg S, et al. Proc Natl Acad Sci U S A. 2008 Nov 4;105(44):17079-84. doi: 10.1073/pnas.0806092105. Epub 2008 Oct 29. Proc Natl Acad Sci U S A. 2008. PMID: 18971340 Free PMC article.
97 results